견적문의

DURHAM, ENGLAND--( / )--Today, Pragmatic Semiconductor was honoured to welcome HRH The Princess Royal to officially open the UK’s first 300mm semiconductor wafer fabrication line (fab) at Pragmatic Park in Durham. The advanced manufacturing facility produces chips based on Pragmatic’s innovative and unique flexible integrated circuit technology. HRH The Princess Royal was hosted by David Moore, CEO, Pragmatic Semiconductor, with a tour of the clean room and facilities, followed by an unveiling of a site plaque to mark the occasion. Attendees included key customers, ecosystem partners, investors and government officials.

Pragmatic’s FlexICs are low-cost, more sustainable alternatives to silicon chips, ultra-thin, with a flexible form factor they enable connect, sense and compute capabilities, fuelling the Internet of Things (IoT) across multiple sectors including consumer, industrial, healthcare and beyond. The company’s mission is to provide item level intelligence to trillions of smart objects over the next decade across a wide range of applications with significant opportunities in smart packaging of fast-moving consumer goods that will significantly improve levels of reuse and recycling, transforming waste management, and enabling a circular economy. Other use cases include wearables, sensors and flexible controllers.

Pragmatic Park has capacity to host up to nine fabrication lines, each capable of producing billions of chips per year. Pragmatic’s pioneering sustainable approach extends to its manufacturing, using fewer process steps and a more concentrated footprint, than standard silicon fabs. The company’s innovative, optimised manufacturing process supports extremely rapid production cycles of less than 48 hours, at very low cost. The manufacturing process also uses significantly less energy and less water than typical silicon manufacturing, and fewer harmful gases. Pragmatic’s modular ‘Fab-in-a-Box’ approach, supports co-location of end-to-end FlexIC manufacturing at customers sites, rationalising extended supply chains and providing additional levels of security and resilience. The manufacturing facility enables the company to meet the growing demand for its unique technology from customers worldwide. Over the next five years Pragmatic anticipates creating over 500 highly skilled jobs in the North-East of England and Cambridge.

Dave Moore, CEO, Pragmatic Semiconductor said: “Today’s official opening marks a key milestone in Pragmatic’s growth trajectory and for the UK on the global semiconductor stage. I am incredibly proud of what the team has achieved and the ambition of our mission to enable item level intelligence in over a trillion sustainable, smart items over the next decade. Such intelligence at scale has the power to accelerate the digital transformation across industries. Sustainability is at the very core of our technology and extends to how FlexICs enable our customers to further drive innovations and pathways through their products and services towards global net zero goals.”

Francisco Melo, President Solutions Group, Avery Dennison said: “The key to any effective collaboration is a shared mindset. Pragmatic’s innovative approach is reflective of our own, as is its commitment to helping solve business challenges. The opening of an advanced manufacturing chip facility is fantastic news for all technology innovators. Congratulations to Pragmatic on such an important and impressive achievement. I look forward to our clients harnessing the potential of Pragmatic's flexible integrated circuits as part of our evolving inlay portfolio.”

Simon Little, Banking & Investments Director, UKIB and Pragmatic Board member said: “The Bank invested in Pragmatic to support low carbon domestic manufacturing of semiconductors in the UK. The official opening of Pragmatic Park in Durham marks a pivotal next step in its journey, and we look forward to seeing the long-term impact of our investment, as Pragmatic scales up its operation and creates highly skilled jobs here in the North-East.”

Niranjan Sirdeshpande, Global Head of M&G’s Catalyst strategy and Pragmatic Board member said: “The UK has a very supportive ecosystem for providing early-stage funding, but it becomes challenging for businesses looking for later stage capital. By providing growth equity to enterprising tech disruptors such as Pragmatic, M&G’s ￡5 billion Catalyst strategy can help them to scale, provide expertise and partner with them all the way to success. Put to work in this way, patient capital can support economic growth and capture value for peoples‘ pensions and savings as we transition to a more sustainable economy. We are proud to support Pragmatic’s work in Durham with tech advancement in this critical part of the UK’s national infrastructure.”

About Pragmatic Semiconductor

Pragmatic is revolutionising semiconductor fabrication with ultra-low-cost, flexible integrated circuit (FlexIC) technology that makes it quick and easy to embed intelligence almost anywhere.

With rapid cycle times that substantially accelerate time to market, its foundry provides high-volume fabrication at a fraction of the cost of silicon, with a significantly lower environmental impact.

View source version on businesswire.com:The UK’s first 300mm semiconductor fabrication line at Pragmatic Park, Durham, UK (Photo: Business Wire)

SEOUL, SOUTH KOREA--( / )--Veeva Systems (NYSE: VEEV) announced that LSK Global Pharma Services Co. Ltd, a leading Korean contract research 미로면홀덤대회 쿨TV organization (CRO), has adopted Veeva Vault eTMF, Veeva Vault CTMS, and Veeva SiteVault Free. With Veeva Vault Clinical applications, LSK Global PS 미로면홀덤대회 뽀바이TV can streamline trial management and remotely collaborate with study monitors for document review and verification.

“As a leading CRO, our aim is to run faster, more efficient trials,” said Young-Jack Lee, Ph.D. and president of LSK Global Pharma Services Co. Ltd. 미로면홀덤대회 fx노출 “Veeva Vault Clinical applications enable us to operate remote trials, provides 미로면홀덤대회 full visibility into end-to-end trial activities, and improves our collaboration with sponsors.” 주천면맞고 분당과외

Vault eTMF (electronic trial master file) and Vault CTMS (clinical 잡소리닷컴 Vaultmanagement system) are part of the Veeva Vault Clinical Suite, the industry’s first cloud platform that unifies clinical data management and operations. SiteVault Free 주천면맞고 카지노부대 simplifies research by replacing paper-based processes. Together, these 미로면홀덤대회 토토마켓 applications enable LSK Global PS to accelerate trial execution and deliver real-time visibility within a short timeframe. 미로면홀덤대회 네이버블로그검색등록

“We are proud to support LSK Global PS,” said Chris Shim, Veeva vice president of Vault R&D and Quality Asia. “With Veeva Vault Clinical applications, LSK Global PS 미로면홀덤대회 키워드광고비용 is innovating their clinical trial processes and running faster, high-quality 미로면홀덤대회 광고대행사 studies.”

To learn how 주천면맞고 바이럴마케팅 Vault Clinical Suite is helping CROs to streamline clinical trial processes 미로면홀덤대회 and information exchange, 미로면홀덤대회 네이버검색등록 트레비TV Toveeva.com/Clinical.

Additional 미로면홀덤대회 블로그상단노출 Information

Connect 야동공유 Connect미로면홀덤대회 최예진 Veeva APAC on 주천면맞고 LinkedIn: linkedin.com/company/veeva-systems-apac 미로면홀덤대회 블로그프로그램

Follow @veevasystems on 미로면홀덤대회 김이브님 Twitter: twitter.com/veevasystems 미로면홀덤대회 셀리의방송국

Like Veeva on 미로면홀덤대회 네이버블로그상위노출방법 주천면맞고 네이버블로그상위노출방법 Facebook: 미로면홀덤대회 현아아이스크림mr제거 카지노내국인 Like

일본외국인카지노 About미로면홀덤대회 Veeva 미로면홀덤대회 i-scream알림장 Systems

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 975 customers, ranging from 미로면홀덤대회 서윤 the world’s largest pharmaceutical companies to emerging biotechs. As a Public 레알스포르팅히혼 VeevaCorporation, Veeva is committed to balancing the interests 미로면홀덤대회 가비j of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

피그AV Forward-looking미로면홀덤대회 슈기 주천면맞고 슈기 Statements 미로면홀덤대회 아이스크림안무

This release contains forward-looking statements, including the market demand 미로면홀덤대회 미쓰에이남자없이잘살아인기가... for and acceptance 섹시동영상 ThisVeeva’s products and services, the results from use of Veeva’s products and services, and general business conditions (including the on-going impact of COVID-19), particularly within the life sciences industry. 미로면홀덤대회 야잘알야사 Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these 주천면맞고 제시카다리 expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements 미로면홀덤대회 싸고넷 are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended October 31, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.

About LSK Global Pharma 미로면홀덤대회 이브알바 Services 미로면홀덤대회 조권미니홈피 Co., Ltd 주천면맞고 초콜릿복근

LSK Global Pharma Services Co., Ltd.(), established in 2000 in Korea, is the 미로면홀덤대회 가인노스텔지아 nation’s largest integrated contract research 미로면홀덤대회 제아 organization 주천면맞고 가인가슴성형전 (CRO) that has provided therapeutic area-specific services across oncology, cardiovascular disease and endocrinology.

LSK Global PS is a full-service CRO encompassing all of the major areas 미로면홀덤대회 현아장현승키스 of clinical research, 섹시동영상 LSKclinical trials from phase I to IV, investigator-led clinical studies, PMS (post-marketing surveillance) studies, 미로면홀덤대회 AV다바 safety studies and observational studies. In addition, it provides consulting services for 미로면홀덤대회 뮤직뱅크버블팝 new drug development, regulatory affairs, study start-up, medical writing and research, clinical operation, project management, data management, statistical analysis, pharmacovigilance (PV), epidemiological research, and quality assurance.

LSK Global PS has conducted 1,277 clinical studies, including 144 global clinical studies and 110 IND studies, since its foundation (as of December 2020). It is the first Korean CRO to win a contract for an FIH (first-in-human) phase I study of an anticancer agent from a multinational pharmaceutical company, an achievement 미로면홀덤대회 살빠지는아이돌춤 that was especially meaningful because LSK Global PS was competing 미로면홀덤대회 against large global CROs to win this contract. Also, LSK Global PS has successfully completed a large-scale global phase III trial for an anticancer agent, which was conducted in 95 sites in 12 countries including the US, Europe, and Asia.

In March 2017, LSK Global PS became the first Korean CRO which acquired the ‘ISO (International Organization for Standardization) 9001:2015’ certification for Quality Management Systems in the entire 미로면홀덤대회 수지섹시 areas of services relevant with clinical trials. In December 2019, it became the 미로면홀덤대회 first Korean CRO to acquire the ‘ISO 37001’ certification for Anti-Bribery Management Systems.

LSK Global PS also 주천면맞고 맥심7월호 became the first Korean CRO to establish 섹시동영상 LSKPV branch office in Europe in May 2019 and a 미로면홀덤대회 하스미쿠레아 DM (Data Management) branch office in Taiwan in February 2020.

View source 주천면맞고 maxim잡지 version 미로면홀덤대회 맥심고딩녀 on businesswire.com:Korea Newswire 미로면홀덤대회 임수정각선미 distributes your news across every 미로면홀덤대회 길거리각선미 media channels through the industry’s largest press release distribution network